Health Products Regulatory Authority (HPRA) – Guide to Biosimilars for Healthcare Professionals (August 2020)
National Cancer Control Programme – NCCP Guidance on the use of Biosimilar Medicines in Cancer Treatment (version 4 May 2021)
HPRA – Biologicals and Biosimilars: What Patients Should Know
Welcome to
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.